Loading company…
Shenzhen Dingbang Bioscience develops stable isotope drugs and medical devices.
Founded in 2019 and based in Shenzhen, China, Shenzhen Dingbang Bioscience focuses on stable isotope drug research, manufacturing, sales, and related services. Its drug development includes isotopes such as 2H, 10B, 13C, and 18O, with applications including medical imaging and disease screening. In July 2022, it raised an undisclosed amount in Series A funding from Yanghe Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in